ArticleScientific reports2025
Nutritional value, antibacterial activity, ACE and DPP IV inhibitory of red pomegranate seeds protein and peptides.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unlocking the Functional Potential of Pecan Nut Cake: A Study on Bioactive Peptide Production.Foods (Basel, Switzerland) · 2026Article
- Exploring Bioactive Compounds from Fruit and Vegetable By-Products with Potential for Food and Nutraceutical Applications.Foods (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the challenges related to food and agriculture industries is the production of waste and by-products. In this study, red pomegranate seeds (PS) was selected as a by-product (from oil extraction) for the production of bioactive hydrolysate (with Alcalase, pancreatin, trypsin and pepsin). The composition of essential (~ 23.3%), hydrophobic (~ 32.9%), antioxidant (~ 13.9%) amino acids, and PER index (~ 2.1) especially in hydrolysates by alcalase (H-Al) indicated the nutritional value, antioxidant activity and high digestibility of hydrolysate. Secondary structures and amide regions (I, II and III) were identified in PS-protein. Enzymolysis led to the improvement of solubility, emulsification and foaming capacity of PS-protein, especially in acidic conditions. The water and oil holding capacity were also affected by the type of proteases. The most biological activities (DPPH, ABTS, OH, NO radicals scavenging, reducing power, total antioxidant and metal-ions chelating activities), also, Angiotensin I-converting enzyme (ACE) (50.1%) and Dipeptidyl peptidase-4 (DPP-IV) (61.2%) inhibition were achieved through hydrolysis using Alcalase and pancreatin. While, the highest antibacterial effect (E. coli and S. aureus) was obtained after hydrolysis with Alcalase. PS- hydrolysate can be considered as a natural nutritious, functional, antioxidant, preservative, blood pressure lowering and antidiabetic compounds in food formulations and dietary supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.